HomeCompareCNCE vs ADC

CNCE vs ADC: Dividend Comparison 2026

CNCE yields 23.89% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADC wins by $86.5K in total portfolio value· pulled ahead in Year 9
10 years
CNCE
CNCE
● Live price
23.89%
Share price
$8.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$92.5K
Annual income
$10,014.51
Full CNCE calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — CNCE vs ADC

📍 ADC pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCNCEADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CNCE + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CNCE pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNCE
Annual income on $10K today (after 15% tax)
$2,031.06/yr
After 10yr DRIP, annual income (after tax)
$8,512.33/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, ADC beats the other by $60,165.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNCE + ADC for your $10,000?

CNCE: 50%ADC: 50%
100% ADC50/50100% CNCE
Portfolio after 10yr
$135.7K
Annual income
$45,405.91/yr
Blended yield
33.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

CNCE
Analyst Ratings
16
Buy
1
Hold
Consensus: Buy
Altman Z
2.4
Piotroski
1/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNCE buys
0
ADC buys
0
No recent congressional trades found for CNCE or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCNCEADC
Forward yield23.89%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$92.5K$178.9K
Annual income after 10y$10,014.51$80,797.29
Total dividends collected$57.3K$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: CNCE vs ADC ($10,000, DRIP)

YearCNCE PortfolioCNCE Income/yrADC PortfolioADC Income/yrGap
1$13,089$2,389.49$10,990$580.36+$2.1KCNCE
2$16,929$2,923.10$12,301$860.26+$4.6KCNCE
3$21,647$3,533.17$14,104$1,298.62+$7.5KCNCE
4$27,385$4,222.32$16,691$2,008.16+$10.7KCNCE
5$34,294$4,992.02$20,580$3,205.09+$13.7KCNCE
6$42,537$5,842.50$26,754$5,330.02+$15.8KCNCE
7$52,287$6,772.75$37,196$9,345.14+$15.1KCNCE
8$63,728$7,780.57$56,244$17,523.09+$7.5KCNCE
9← crossover$77,051$8,862.62$94,286$35,736.21$17.2KADC
10$92,459$10,014.51$178,949$80,797.29$86.5KADC

CNCE vs ADC: Complete Analysis 2026

CNCEStock

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Full CNCE Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this CNCE vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNCE vs SCHDCNCE vs JEPICNCE vs OCNCE vs KOCNCE vs MAINCNCE vs NNNCNCE vs EPRTCNCE vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.